Chlamydia pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up.
The role of Chlamydia pneumoniae infection in pathogenesis and prognostic stratification of patients with acute coronary syndromes is still unclear. However, a limitation of many studies is the evaluation of the long-term prognostic role of a sample obtained during the acute phase, whereas the assessment of the temporal trend of antibody titers could be more useful. One-hundred and fourteen consecutive patients with acute coronary syndromes (71 with acute myocardial infarction and 43 with unstable angina) were studied. Blood samples were obtained immediately after hospital admission and 1, 3, 6 and 12 months after the acute event. The microimmunofluorescence test was used to detect C. pneumoniae specific antibodies. The incidence of new coronary events (death, myocardial infarction, recurrent angina) was recorded during the 1-year follow-up period. No significant difference was found between patients with (n = 35) or without (n = 79) new coronary events (N.C.E.) regarding baseline and serial values of C. pneumoniae antibodies. The rate of high titers at any time of follow-up was also similar in the two groups: IgG > or =1:512 were present in 52%, 64%, 55% and 32% of N.C.E.+ patients, and in 48%, 54%, 52% and 36% of N.C.E.- patients at 1, 3, 6 and 12 months respectively; IgA > or =1:256 were present in 26%, 23%, 30% and 23% of N.C.E.+ patients and in 20%, 30%, 25% and 19% of N.C.E.- patients at 1, 3, 6 and 12 months respectively. Our data indicate that elevated titers of C. pneumoniae antibodies, even with a serial 1-year evaluation, are not a predictor of future coronary events in patients with acute myocardial infarction or unstable angina.
Romano
S
S
Dept Internal Medicine, Cardiology, University of L'Aquila, L'Aquila, Italy.
Fratini
S
S
Di Pietro
M
M
Schiavoni
G
G
Nicoletti
M
M
Chiarotti
F
F
Del Piano
M
M
Penco
M
M
Sessa
R
R
D000789:Angina, Unstable / Q000150:complications; D000907:Antibodies, Bacterial / Q000032:analysis*; D002690:Chlamydia Infections / Q000150:complications* / Q000000981:diagnostic imaging / Q000276:immunology; D016993:Chlamydophila pneumoniae; D003327:Coronary Disease / Q000150:complications* / Q000000981:diagnostic imaging / Q000276:immunology; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis / Q000302:isolation & purification; D007074:Immunoglobulin G / Q000032:analysis / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D016016:Proportional Hazards Models; D012307:Risk Factors; D014463:Ultrasonography
D000907:Antibodies, Bacterial; D007070:Immunoglobulin A; D007074:Immunoglobulin G